skip to Main Content

Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
A liquid biopsy has shown promise for the early detection and staging of pancreatic ductal adenocarcinoma.

The test — developed by researchers at University of Pennsylvania’s Perelman School of Medicine, Abramson Cancer Center and School of Engineering and Applied Science — could play a valuable role in guiding treatment of the most common form of pancreatic cancer. If detected early, curative-intent surgery is possible. Read more . . . 

Back To Top